Pressure InjuriesNCT07734220
Evaluation of Two Heel Protection Devices to Assess Off-loading Via Pressure Mapping.
An observational study of Pressure Injuries, run by Medline Industries at 1 site in United States.
Trial summary
The goal of this trial is to compare heel off-loading capabilities of two products Read more about this study
- Who is it for?
- Ages 22 years and olderHealthy volunteers can take part
- Conditions the study is for
- Pressure Injuries
- What is being tested?
- HeelMedix Basic & EHOB Waffle
- Type of treatment
- Medical device
- How many people
- 25 participants
- Where
- 1 siteUnited States
- Study dates
- 8 Jul 2026to 22 Jul 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 22 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Total number of participants, N=25
Who may be able to join
- Individual is ≥ 22 years old
- Self-reported to be in healthy condition.
- Able to remain seated on a hard surface such as the floor and wear a heel protectant boot for at least thirty minutes.
- Able to understand and willing to carry out instructions for this study.
- Has a calf circumference of 11-19 inches
Who cannot join
- Self-reported to have pre-existing pathology associated with lower extremities
- Individual has a calf circumference of less than 11 inches or greater than 19 inches
- Individual is employed in a division of Medline Industries, LP under which the study product(s) are developed
- Individual is sensitive to the materials of the study product(s)
- Individual is considered inappropriate for inclusion by the principal investigator
- Medline Contractors
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Evaluation of Two Heel Protection Devices to Assess Off-loading Via Pressure Mapping
The goal of this trial is to compare heel off-loading capabilities of two products
Read the detailed description
Pressure injuries to the heel remain a major concern for immobile or limited mobility patients, as the heel is one of the highest risk sites for tissue breakdown. Offloading boots are widely used to redistribute lower extremity pressure and minimize concentrated forces at the heel. Internal Medline studies and industry literature reinforce the clinical relevance of pressure mapping to quantify heel offloading effectiveness across devices. Prior work has shown that heel offloading boots can differ widely in their ability to reduce pressure at the heel and ankle joint region. This study will quantitatively compare the heel off-loading capabilities of the Medline HeelMedix® Basic Heel Boot (hereafter referred to as HeelMedix® Basic) and the EHOB Foot Waffle Protector (hereafter referred to as EHOB Waffle) using pressure mapping in healthy volunteers. The data from this study design will allow for a comparative assessment of the heel offloading capabilities between two heel offloading boots.
- Conditions
- Pressure Injuries
- Being tested
- HeelMedix Basic & EHOB Waffle
- Keywords
- pressure mapping
- Medical subject headings
- Pressure Ulcer
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
HeelMedix Basic & EHOB WaffleDevice
Participants will then have a baseline pressure mapping measurement taken, where they will be instructed to outstretch their right leg in front of them onto the BPMS pressure mat. The baseline peak and average pressures of the lower extremity in the heel, calf and combination of heel and calf as shown on the TekScan software connected to the mat will be recorded on the designated CRF. Pressure minimum and standard deviation will also be recorded.
Once baseline measurements are complete, the first of two study devices will be applied to the participant, and they will place their leg back on the pressure mat in the same manner as the baseline measurement. Peak and average pressures of the lower extremity while wearing the first study device, in the heel, calf and combination of heel and calf as shown on the TekScan software connected to the mat will be recorded on the designated CRF. Pressure minimum and standard deviation will also be recorded.
Steps will be repeated for 2nd device.
What is being measured
The primary outcome is the main question the study is designed to answer.
To evaluate heel offloading capabilities of two heel protection boot devices
The primary endpoint will be the percentage change in peak and average pressures in the lower extremity (measuring heel, calf and combination)
Measured: 3-6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jul 2026
- Study start8 Jul 2026
- Primary completion22 Jul 2026
- Study completion22 Jul 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pressure InjuriesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 25 participants (actual)
Sponsor and investigators
- Lead sponsor
- Medline Industries
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Gregory J Gomez, RN BSN MPH, Principal investigator, Medline Industries, LP
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07734220
- Sponsor's protocol ID
- MED-2025-DIV75-002
- Status last verified
- Jul 2026
- First submitted
- 24 Jul 2026
- Last updated
- 29 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 29 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Two Heel Protection Devices to Assess Off-loading Via Pressure Mapping
- ClinicalTrials.gov ID
- NCT07734220
- Acronym / sponsor ID
- MED-2025-DIV75-002
- Conditions
- Pressure Injuries
- Keywords
- pressure mapping
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 25 participants (actual)
- Lead sponsor
- Medline IndustriesIndustry (pharma, biotech, devices)
- Study start
- 8 Jul 2026 (actual)
- Primary completion
- 22 Jul 2026 (actual)
- Study completion
- 22 Jul 2026 (actual)
- First posted
- 29 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this trial is to compare heel off-loading capabilities of two products
Detailed description
Pressure injuries to the heel remain a major concern for immobile or limited mobility patients, as the heel is one of the highest risk sites for tissue breakdown. Offloading boots are widely used to redistribute lower extremity pressure and minimize concentrated forces at the heel. Internal Medline studies and industry literature reinforce the clinical relevance of pressure mapping to quantify heel offloading effectiveness across devices. Prior work has shown that heel offloading boots can differ widely in their ability to reduce pressure at the heel and ankle joint region. This study will quantitatively compare the heel off-loading capabilities of the Medline HeelMedix® Basic Heel Boot (hereafter referred to as HeelMedix® Basic) and the EHOB Foot Waffle Protector (hereafter referred to as EHOB Waffle) using pressure mapping in healthy volunteers. The data from this study design will allow for a comparative assessment of the heel offloading capabilities between two heel offloading boots.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 22 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Total number of participants, N=25
Key inclusion criteria (5 listed)
- Individual is ≥ 22 years old
- Self-reported to be in healthy condition.
- Able to remain seated on a hard surface such as the floor and wear a heel protectant boot for at least thirty minutes.
- Able to understand and willing to carry out instructions for this study.
- Has a calf circumference of 11-19 inches
Key exclusion criteria (6 listed)
- Self-reported to have pre-existing pathology associated with lower extremities
- Individual has a calf circumference of less than 11 inches or greater than 19 inches
- Individual is employed in a division of Medline Industries, LP under which the study product(s) are developed
- Individual is sensitive to the materials of the study product(s)
- Individual is considered inappropriate for inclusion by the principal investigator
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| HeelMedix Basic & EHOB WaffleParticipants will then have a baseline pressure mapping measurement taken, where they will be instructed to outstretch their right leg in front of them onto the BPMS pressure mat. The baseline peak and average pressures of the lower extremity in the heel, calf and combination of heel and calf as shown on the TekScan software connected to the mat will be recorded on the designated CRF. Pressure minimum and standard deviation will also be recorded. Once baseline measurements are complete, the first of two study devices will be applied to the participant, and they will place their leg back on the pressure mat in the same manner as the baseline measurement. Peak and average pressures of the lower extremity while wearing the first study device, in the heel, calf and combination of heel and calf as shown on the TekScan software connected to the mat will be recorded on the designated CRF. Pressure minimum and standard deviation will also be recorded. Steps will be repeated for 2nd device. | Device | – |
Primary outcome
To evaluate heel offloading capabilities of two heel protection boot devices
Time frame: 3-6 months
The primary endpoint will be the percentage change in peak and average pressures in the lower extremity (measuring heel, calf and combination)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jul 2026.
Related trials for Pressure Injuries
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Enrolling by invitation
Personalized Ventilator Settings for Patients on ECMO
Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation
RecruitingObservational study
Intracranial Pressure Monitoring in Moderate Traumatic Brain Injury
Moderate Traumatic Brain Injury
Recruiting
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Acute Hypoxic Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS)
Recruiting
Efficacy and Safety of ZKARE® Gel and Its Accessory ZKAPI® in the Treatment of Chronic Ulcers.
Chronic Ulcers
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gregory J Gomez, RN BSN MPH principal investigator
Medline Industries, LP
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pressure Injuries, run by Medline Industries at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To evaluate heel offloading capabilities of two heel protection boot devices (time frame: 3-6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2026.